Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 7931314, 8 pages
http://dx.doi.org/10.1155/2016/7931314
Research Article

The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications

Department of Endocrinology, Jiangsu Province Hospital of Traditional Chinese Medicine (The First Affiliated Hospital of Nanjing University of Chinese Medicine), Nanjing, China

Received 16 September 2016; Accepted 27 November 2016

Academic Editor: Jairo Kennup Bastos

Copyright © 2016 Yue Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “9. Microvascular complications and foot care,” Diabetes Care, vol. 38, supplement 1, pp. S58–S66, 2014. View at Publisher · View at Google Scholar
  2. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Javed, U. Alam, and R. A. Malik, “Burning through the pain: treatments for diabetic neuropathy,” Diabetes, Obesity and Metabolism, vol. 17, no. 12, pp. 1115–1125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. American Diabetes Association, “8. Cardiovascular disease and risk management,” Diabetes Care, vol. 39, supplement 1, pp. S60–S71, 2016. View at Publisher · View at Google Scholar
  5. D. M. Nathan, “Diabetes: advances in diagnosis and treatment,” The Journal of the American Medical Association, vol. 314, no. 10, pp. 1052–1062, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Haw, K. M. Narayan, and M. K. Ali, “Quality improvement in diabetes—successful in achieving better care with hopes for prevention,” Annals of the New York Academy of Sciences, vol. 1353, no. 1, pp. 138–151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Tricco, N. M. Ivers, J. M. Grimshaw et al., “Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis,” The Lancet, vol. 379, no. 9833, pp. 2252–2261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Y. Rhee and Y. S. Kim, “Peripheral arterial disease in patients with type 2 diabetes mellitus,” Diabetes and Metabolism Journal, vol. 39, no. 4, pp. 283–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. X.-L. Tong, L. Dong, L. Chen, and Z. Zhen, “Treatment of diabetes using traditional Chinese medicine: past, present and future,” American Journal of Chinese Medicine, vol. 40, no. 5, pp. 877–886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-L. Zhao, Y. Sui, C.-F. Qiao et al., “Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression,” Diabetes, vol. 61, no. 4, pp. 933–943, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. G.-D. Sun, C.-Y. Li, W.-P. Cui et al., “Review of herbal traditional chinese medicine for the treatment of diabetic nephropathy,” Journal of Diabetes Research, vol. 2016, Article ID 5749857, 18 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. S. W. Seto, G. Y. Yang, H. Kiat, A. Bensoussan, Y. W. Kwan, and D. Chang, “Diabetes mellitus, cognitive impairment, and traditional Chinese medicine,” International Journal of Endocrinology, vol. 2015, Article ID 810439, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-M. Zhang, F.-X. Liang, and R. Chen, “Ancient records and modern research on the mechanisms of Chinese herbal medicines in the treatment of diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 747982, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-T. Zhang and J.-G. Jiang, “Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications,” Expert Opinion on Investigational Drugs, vol. 21, no. 11, pp. 1625–1642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Kai, P. Michela, P. Antonio, and P. Annamaria, “Biological active ingredients of traditional Chinese herb astragalus membranaceus on treatment of diabetes: a systematic review,” Mini-Reviews in Medicinal Chemistry, vol. 15, no. 4, pp. 315–329, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Pu, X.-N. Geng, F. Yu, H.-G. Liang, and L.-W. Shi, “Liuwei Dihuang Pills (六地黄) enhance the effect of Western medicine in treating type 2 diabetes: a meta-analysis of randomized controlled trials,” Chinese Journal of Integrative Medicine, vol. 19, no. 10, pp. 783–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-S. Li, W.-Y. Zheng, S.-X. Lou, X.-W. Lu, and S.-H. Ye, “Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy,” Chinese Journal of Integrative Medicine, vol. 15, no. 1, pp. 26–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R.-X. Zhang, M.-X. Li, and Z.-P. Jia, “Rehmannia glutinosa: review of botany, chemistry and pharmacology,” Journal of Ethnopharmacology, vol. 117, no. 2, pp. 199–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Asgary, R. Kelishadi, M. Rafieian-Kopaei, S. Najafi, M. Najafi, and A. Sahebkar, “Investigation of the lipid-modifying and antiinflammatory effects of cornus mas L. supplementation on dyslipidemic children and adolescents,” Pediatric Cardiology, vol. 34, no. 7, pp. 1729–1735, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Tian, H. Chen, and Y.-Y. Zhao, “Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review,” Journal of Ethnopharmacology, vol. 158, pp. 373–387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sun, “Biological activities and potential health benefits of polysaccharides from Poria cocos and their derivatives,” International Journal of Biological Macromolecules, vol. 68, pp. 131–134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-L. Ríos, “Chemical constituents and pharmacological properties of Poria cocos,” Planta Medica, vol. 77, no. 7, pp. 681–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Shi, Z. Yao, J. Xu, and D. T. Yew, “Effects of Gingko Extract (EGb761) on oxidative damage under different conditions of serum supply,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 1, pp. 61–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. H. Ryu, H. Y. Han, S. Y. Lee et al., “Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time,” Thrombosis Research, vol. 124, no. 3, pp. 328–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Nishida and H. Satoh, “Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta,” Life Sciences, vol. 72, no. 23, pp. 2659–2667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-Y. Huang, C. Jeng, S.-C. Kao, J. J.-H. Yu, and D.-Z. Liu, “Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy,” Clinical Nutrition, vol. 23, no. 4, pp. 615–621, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Y. C. Poon, K. L. Ong, and B. M. Y. Cheung, “Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications,” Journal of Diabetes, vol. 3, no. 3, pp. 184–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Xie and L. Du, “Diabetes is an inflammatory disease: evidence from traditional Chinese medicines,” Diabetes, Obesity and Metabolism, vol. 13, no. 4, pp. 289–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. Kohner, “Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?” Diabetic Medicine, vol. 25, no. 2, pp. 20–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus